Jason Ruth, PhD, is the CDCN's Chief Scientific Officer, and a postdoctoral fellow in Levi Garraway's laboratory at the Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard. He is passionate about maximizing the impact that the CDCN has on patients by identifying research areas that further understanding about Castleman Disease in a clinically meaningful way. He was previously an HHMI-NIBIB Interfaces Scholar at the University of Pennsylvania, where he received his PhD in Bioengineering.  During his thesis work he developed methods to study cancer cells resistant to targeted therapy in Lewis Chodosh's laboratory, in the Department of Cancer Biology at the University of Pennsylvania's Perelman School of Medicine.

Hear Jason's story in this video.